Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Growth Hormone149 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A26708 | 19923096 | Orv Hetil | [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease]. | 2009 | Details |
A27343 | 18612181 | Endocr J | Metabolic co-morbidities revealed in patients with childhood-onset adult GH deficiency after cessation of GH replacement therapy for short stature. | 2008 | Details |
A27402 | 18462969 | Growth Horm IGF Res | Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletion - preliminary report. | 2008 | Details |
A27747 | 19669352 | Hepatol Int | Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease. | 2007 | Details |
A27830 | 17324404 | Gastroenterology | Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency. | 2006 | Details |
A28074 | 16506276 | Diabetes Metab Res Rev | Diabetes in chronic liver disease: from old concepts to new evidence. | 2006 | Details |
A35951 | 19347015 | Nat Rev Gastroenterol Hepatol | Endocrine and liver interaction: the role of endocrine pathways in NASH. | 2009 | Details |
A37436 | 15690087 | J Clin Invest | SOCS2 negatively regulates growth hormone action in vitro and in vivo. | 2005 | Details |
A42361 | 34766492 | Probl Endokrinol (Mosk) | [Hepatopulmonary syndrome: a rare manifestation of cirrhosis in patient with diencephalic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma]. | 2021 | Details |
A43477 | 31611037 | Lancet HIV | Tesamorelin, liver fat, and NAFLD in the setting of HIV. | 2019 | Details |
A44430 | 28655407 | Gastroenterol Hepatol | Turner syndrome as a cause of liver cirrhosis. | 2017 | Details |
A44598 | 28043364 | Theriogenology | Inhibition of peripubertal sheep mammary gland development by cysteamine through reducing progesterone and growth factor production. | 2016 | Details |
A44774 | 27351453 | Hepatology | G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice. | 2016 | Details |
A45248 | 27508202 | J Hepatocell Carcinoma | Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma. | 2015 | Details |
A45401 | 24793205 | J Pediatr | Abnormalities in the growth hormone axis and risk of nonalcoholic steatohepatitis: active player or innocent bystander? | 2014 | Details |
A45422 | 24691865 | Hepatology | Decreased muscle mass in nonalcoholic fatty liver disease: new evidence of a link between growth hormone and fatty liver disease? | 2014 | Details |
A46067 | 21303949 | Endocrinology | Growth hormone-dependent pathogenesis of human hepatic steatosis in a novel mouse model bearing a human hepatocyte-repopulated liver. | 2011 | Details |
A46105 | 21084450 | Endocrinology | GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism. | 2010 | Details |
A46874 | 12003400 | Am J Gastroenterol | Growth hormone plasma levels in nonalcoholic fatty liver disease. | 2002 | Details |
A47256 | 21087523 | J Transl Med | Exploring the molecular mechanisms underlying the potentiation of exogenous growth hormone on alcohol-induced fatty liver diseases in mice. | 2010 | Details |
A47578 | 6416854 | Eur J Clin Invest | Hormone and metabolite profiles in alcoholic liver disease. | 1983 | Details |
A48143 | 21519236 | Curr Opin Clin Nutr Metab Care | Osteocalcin: a new link between bone and energy metabolism. Some evolutionary clues. | 2011 | Details |
A48520 | 34965924 | Drug Metab Dispos | Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes. | 2021 | Details |
A48717 | 30817309 | Rev Neurosci | The effects of dietary methionine restriction on the function and metabolic reprogramming in the liver and brain - implications for longevity. | 2019 | Details |
A48932 | 24090942 | Best Pract Res Clin Gastroenterol | Liver abnormalities and endocrine diseases. | 2013 | Details |
A49200 | 12740357 | Gut | Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency. | 2003 | Details |
A49353 | 35780715 | Growth Horm IGF Res | Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2022 | Details |
A49358 | 35779256 | J Clin Endocrinol Metab | The GH/IGF-1 axis is associated with intrahepatic lipid content and hepatocellular damage in overweight/obesity. | 2022 | Details |
A49392 | 35765700 | Hepatol Commun | Growth hormone deficiency and NAFLD: An overlooked and underrecognized link. | 2022 | Details |
A50084 | 35533183 | PLoS One | Insights from a high-fat diet fed mouse model with a humanized liver. | 2022 | Details |
A50272 | 35448486 | Metabolites | Nonalcoholic Fatty Liver Disease and Endocrine Axes-A Scoping Review. | 2022 | Details |
A50456 | 35384023 | Clin Endocrinol (Oxf) | Relationship between growth hormone deficiency and nonalcoholic fatty liver disease in patients with pituitary stalk interruption syndrome. | 2022 | Details |
A51448 | 35319489 | Endocrinol Diabetes Metab Case Rep | A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone. | 2022 | Details |
A51540 | 35457118 | Int J Mol Sci | Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL). | 2022 | Details |
A51659 | 35187139 | Front Vet Sci | Differentiation of Subclinical Ketosis and Liver Function Test Indices in Adipose Tissues Associated With Hyperketonemia in Postpartum Dairy Cattle. | 2022 | Details |
A51679 | 34998544 | J Dairy Sci | Temporal profiles describing markers of inflammation and metabolism during the transition period of pasture-based, seasonal-calving dairy cows. | 2022 | Details |
A51773 | 34222458 | World J Clin Cases | Growth hormone cocktail improves hepatopulmonary syndrome secondary to hypopituitarism: A case report. | 2021 | Details |
A52081 | 31565213 | Ther Adv Endocrinol Metab | Update on the synergistic effect of HSL and insulin in the treatment of metabolic disorders. | 2019 | Details |
A52233 | 29895033 | Front Horm Res | Metabolic Syndrome in Hypopituitarism. | 2018 | Details |
A52360 | 28194444 | JCI Insight | Adipocyte JAK2 mediates growth hormone-induced hepatic insulin resistance. | 2017 | Details |
A52530 | 25941430 | J Clin Exp Hepatol | Study of the effects of cyclooxygenase-2 inhibitor on the promotion of hepatic tumorigenesis in rats fed a high fat diet. | 2015 | Details |
A52569 | 25497809 | J Dairy Sci | Body condition score at calving affects systemic and hepatic transcriptome indicators of inflammation and nutrient metabolism in grazing dairy cows. | 2014 | Details |
A52702 | 23303913 | Physiol Rev | Pathophysiology of human visceral obesity: an update. | 2013 | Details |
A52739 | 22564914 | Mol Cell Endocrinol | Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development. | 2012 | Details |
A52800 | 21725989 | Hepatology | Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice. | 2011 | Details |
A53115 | 12625408 | Endocr J | Adult growth hormone deficiency in Japan: results of investigation by questionnaire. | 2002 | Details |
A53128 | 11729749 | Adv Anat Embryol Cell Biol | Cooperation of liver cells in health and disease. | 2001 | Details |
A53168 | 8262497 | Horm Res | Endocrine-metabolic pattern and adipose tissue distribution. | 1993 | Details |
A53192 | 1175860 | Diabetes | Metabolic studies in the pyelonephritic rat. | 1975 | Details |